| Previous close | 3.1900 |
| Open | 3.9000 |
| Bid | 1.4900 |
| Ask | 2.8500 |
| Strike | 135.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.8800 - 4.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 55 |
Barrons.comModerna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
After disappointing sales for their Covid vaccines last year, drugmakers are hoping for an August rollout of the updated shot.
ZacksThe Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
ZacksBiotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
© 2024 Yahoo. All rights reserved.